Average Co-Inventor Count = 6.49
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (33 from 1,456 patents)
2. Antaros Medical Ab (1 from 2 patents)
3. Sanofi-Aventis (389 patents)
34 patents:
1. 11352405 - GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis
2. 11046743 - Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes
3. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate
4. 10758592 - Exendin-4 derivatives as dual GLP1/glucagon agonists
5. 10538567 - Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
6. 10519211 - Compounds as peptidic GLP1/glucagon/GIP receptor agonists
7. 10253079 - Functionalized Exendin-4 derivatives
8. 9982029 - Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists
9. 9932381 - Exendin-4 derivatives as selective glucagon receptor agonists
10. 9789165 - Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists
11. 9775904 - Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
12. 9771406 - Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4
13. 9758561 - Dual GLP-1/glucagon receptor agonists derived from exendin-4
14. 9751926 - Dual GLP-1/GIP receptor agonists
15. 9750788 - Non-acylated exendin-4 peptide analogues